Pfizer Financials

Market Capitalization $143.95 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	18.35
Forward PE	8.64
Price to Sales TTM	$2.30
Price to Book MRQ	$1.59
Enterprise to Revenue	2.93
Enterprise to EBITDA	7.86

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	12.62%
Operating Margin	35.17%
Return on Assets TTM	4.79%
Return on Equity TTM	8.62%

Income Statement

Revenue TTM	$62,464,000,000
Revenue per Share TTM	$11.02
Quarterly Revenue Growth	-7.80%
Gross Profit TTM	$46,487,998,464
EBITDA	$23,606,000,000
Net Income to Common TTM	$7,866,999,808
Diluted EPS TTM	$1.38
Quarterly Earnings Growth YoY	-4.80%

Balance Sheet

Total Cash MRQ	$17,319,000,064
Total Cash per Share MRQ	$3.05
Total Debt MRQ	$
Total Debt to Equity MRQ	68.84
Current Ratio MRQ	1.26
Book Value per Share MRQ	$15.89

Cash Flow

Operating Cash Flow TTM	$13,989,000,192
Levered Free Cash Flow TTM	$15,049,249,792

PFE Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	5,666,990,035
Float Shares	5,675,927,880
Avg 10 Volume	40,007,000
Avg 30 Volume	None
Shares Short	106,732,210
Short Ratio	2.67
Short % of Shares	1.88%
% Held by Insiders	0.06%
% Held by Institutions	67.55%

Stock Price Summary

Beta	0.49
Fifty Two Week Low	$20.92
Fifty Two Week High	$31.54
Fifty Two Week Change	-10.52%
Day 50 MA	$23.51
Day 200 MA	$25.79

Dividends and Splits

Forward Annual Dividend Rate	$1.72
Forward Annual Dividend Yield	6.78%
Trailing Annual Dividend Rate	$1.69
Trailing Annual Dividend Yield	6.66%
Payout Ratio	122.46%
Dividend Date	2025-09-02
Ex Dividend Date	2025-07-25
Last Split Factor
Last Split Date	2020-11-17